Healthcare Professionals

Asclera Resources for Healthcare Professionals

Upcoming Webinars

Asclera Upcoming Webinars June 2023

Downloadable Resources PDF Version

June 28 at 1:00pm CST

Surviving the Slow Season:
Strategies for your Aesthetic Practice

With guest speaker Jay Shuffler

purple asclera video icon Link to the Webinar

July 5th at 6:30pm CST

Sclerotherapy in Your Practice with Asclera

1st Wednesday of every month until the end
of the year

purple asclera video iconLink to the Webinar

Recorded Webinars

NOTE:  You will need to register for each webinar in order to view the recording of it.

Video Resources

purple asclera video icon View Video Resources for Healthcare Professionals

Printable Resources

Asclera – Know What to Expect

Asclera, know what to expect.

Downloadable Resources PDF Version

Asclera Consultation Consent


Asclera Consent Form

Downloadable Resources PDF Version

Clinical Experience

Asclera® Injection was evaluated in a multicenter, randomized, double-blind, placebo and comparator-controlled trial (EASI-study) in patients with spider or reticular varicose veins. A total of 338 patients were treated with Asclera® (0.5% for spider veins [n=94], 1% for reticular veins [n=86], sodium tetradecyl sulfate [STS] 1% [n=105], or placebo [0.9% isotonic saline solution] [n= 53]) for either spider or reticular veins.

  • Patients received an intravenous injection in the first treatment session; repeat injections were given 3 and 6 weeks later if the previous injection was evaluated as unsuccessful (defined as 1, 2, or 3 on a 5-point scale)
  • Patients returned at 12 and 26 weeks after the last injection for final assessments. The primary effectiveness endpoint was improvement of veins judged by a blinded panel

Treatment Success1

  • 95% of patients treated with Asclera® showed good improvement or complete treatment success as rated by the blinded panel*
  • Asclera® treatment results were statistically significant when compared to placebo (p<0.0001) for the primary efficacy criterion “improvement of veins”

*Treatment success was rated by a blinded panel on a 5-point scale (1 = worse than before, 2 = same as before, 3 = moderate improvement, 4 = good improvement, 5 = complete treatment success).

Video Resources

Overview and Administration of Asclera

Ampule Opening and Drawing Into Syringe of Asclera

Sclerotherapy Procedure Set-up of Asclera

Patient Evaluation and Therapy of Asclera

Patient Post-Treatment Instructions of Asclera